Rothschild Investment LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.3K Buy
1,390
+88
+7% +$1.48K ﹤0.01% 987
2025
Q1
$20K Sell
1,302
-234
-15% -$3.6K ﹤0.01% 999
2024
Q4
$33.9K Sell
1,536
-820
-35% -$18.1K ﹤0.01% 872
2024
Q3
$42.5K Buy
2,356
+1,994
+551% +$35.9K ﹤0.01% 820
2024
Q2
$5.88K Buy
362
+151
+72% +$2.45K ﹤0.01% 1179
2024
Q1
$2.98K Buy
211
+24
+13% +$339 ﹤0.01% 1182
2023
Q4
$1.95K Buy
+187
New +$1.95K ﹤0.01% 1148
2017
Q4
Sell
-16,577
Closed -$292K 419
2017
Q3
$292K Sell
16,577
-7,650
-32% -$135K 0.03% 345
2017
Q2
$805K Buy
24,227
+15,357
+173% +$510K 0.09% 222
2017
Q1
$285K Buy
8,870
+166
+2% +$5.33K 0.03% 358
2016
Q4
$316K Sell
8,704
-8,689
-50% -$315K 0.04% 333
2016
Q3
$800K Buy
17,393
+263
+2% +$12.1K 0.1% 199
2016
Q2
$860K Sell
17,130
-500
-3% -$25.1K 0.11% 189
2016
Q1
$943K Hold
17,630
0.12% 182
2015
Q4
$1.16M Hold
17,630
0.15% 158
2015
Q3
$995K Hold
17,630
0.13% 177
2015
Q2
$1.04M Buy
17,630
+140
+0.8% +$8.28K 0.12% 191
2015
Q1
$1.09M Hold
17,490
0.13% 175
2014
Q4
$1.01M Buy
17,490
+6,689
+62% +$385K 0.12% 179
2014
Q3
$581K Buy
10,801
+111
+1% +$5.97K 0.07% 272
2014
Q2
$560K Hold
10,690
0.07% 247
2014
Q1
$565K Sell
10,690
-850
-7% -$44.9K 0.08% 248
2013
Q4
$463K Sell
11,540
-700
-6% -$28.1K 0.06% 279
2013
Q3
$462K Hold
12,240
0.07% 262
2013
Q2
$480K Buy
+12,240
New +$480K 0.08% 235